You are here

Article info

Article menu
Immune cell therapies and immune cell engineering
Original research
First immunotherapeutic CAR-T cells against the immune checkpoint protein HLA-G

Authors

  • François Anna Preclinical Department, Invectys, Paris, FranceMolecular Virology and Vaccinology Unit, Virology Department, Pasteur Institute, Paris, Île-de-France, France PubMed articlesGoogle scholar articles
  • Elodie Bole-Richard INSERM UMR1098 RIGHT Interactions hôte-greffon-tumeur – Ingénierie Cellulaire et Génique, Besancon, Franche-Comté, FranceUniversité Bourgogne Franche-Comté, Besançon, FranceEtablissement Français du Sang Bourgogne Franche-Comté, Besançon, France PubMed articlesGoogle scholar articles
  • Joel LeMaoult Service de Recherche en Hémato-Immunologie (SRHI), CEA, Paris, FranceUniversité de Paris, Paris, Île-de-France, France PubMed articlesGoogle scholar articles
  • Marie Escande Preclinical Department, Invectys, Paris, France PubMed articlesGoogle scholar articles
  • Martin Lecomte Preclinical Department, Invectys, Paris, France PubMed articlesGoogle scholar articles
  • Jean-Marie Certoux INSERM UMR1098 RIGHT Interactions hôte-greffon-tumeur – Ingénierie Cellulaire et Génique, Besancon, Franche-Comté, FranceUniversité Bourgogne Franche-Comté, Besançon, FranceEtablissement Français du Sang Bourgogne Franche-Comté, Besançon, France PubMed articlesGoogle scholar articles
  • Philippe Souque Molecular Virology and Vaccinology Unit, Virology Department, Pasteur Institute, Paris, Île-de-France, France PubMed articlesGoogle scholar articles
  • Francine Garnache INSERM UMR1098 RIGHT Interactions hôte-greffon-tumeur – Ingénierie Cellulaire et Génique, Besancon, Franche-Comté, FranceUniversité Bourgogne Franche-Comté, Besançon, FranceEtablissement Français du Sang Bourgogne Franche-Comté, Besançon, France PubMed articlesGoogle scholar articles
  • Olivier Adotevi INSERM UMR1098 RIGHT Interactions hôte-greffon-tumeur – Ingénierie Cellulaire et Génique, Besancon, Franche-Comté, FranceUniversité Bourgogne Franche-Comté, Besançon, FranceEtablissement Français du Sang Bourgogne Franche-Comté, Besançon, France PubMed articlesGoogle scholar articles
  • Pierre Langlade-Demoyen Preclinical Department, Invectys, Paris, France PubMed articlesGoogle scholar articles
  • Maria Loustau Preclinical Department, Invectys, Paris, France PubMed articlesGoogle scholar articles
  • Julien Caumartin Preclinical Department, Invectys, Paris, France PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Julien Caumartin; julien.caumartin{at}invectys.com
View Full Text

Citation

Anna F, Bole-Richard E, LeMaoult J, et al
First immunotherapeutic CAR-T cells against the immune checkpoint protein HLA-G
Journal for ImmunoTherapy of Cancer 2021;9:e001998. doi: 10.1136/jitc-2020-001998

Publication history

  • Accepted February 15, 2021
  • First published March 18, 2021.
Online issue publication 
February 10, 2022

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.